Emphasis on Cancer Type (Pharyngeal Cancer and Laryngeal Cancer); Treatment Type (Radiation Therapy, Surgery, Chemotherapy, Targeted Drug Therapy, and Others); End-user (Hospitals, Ambulatory Surgical Centers, and Others); and Region/Country
Global Throat Cancer Therapeutics Market is expected to grow at a significant rate of around 7.5% during the forecast period. Throat cancer therapeutics services gained prominence in the therapeutics market owing to the increased consumption of alcohol and tobacco. addition to this, investments in oncology departments as well as government awareness programs regarding throat cancer have increased significantly in recent years, which are the key factors that are creating opportunities for the market. For instance, in February 2021, U.S.-based Kura Oncology, Inc., a company focused on providing precision medicines for cancer treatment, received approval for its tipifarnib drug from the FDA. This drug provides therapy to patients suffering from metastatic or recurrent HRAS mutant head and neck squamous cell carcinoma. Many other factors were identified that helped in propelling the market in the forecast period such as the surge in awareness programs regarding throat cancer, the increasing smoking population, rising alcoholism culture are also driving the growth of the market.
Amgen Inc.; AstraZeneca; Bayer AG; Bristol Myers Squibb Company; Celldex Therapeutics; Lilly; Merck KGaA; Pfizer Inc.; Regeneron Pharmaceuticals Inc.; and Sanofi are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst cancer type, pharyngeal cancer category to witness higher CAGR during the forecast period”
Based on cancer type, the market is bifurcated into pharyngeal cancer and laryngeal cancer. The pharyngeal cancer segment is expected to grow with a high CAGR during the forecast period as there is a growing trend of tobacco use, including smoking and chewing tobacco and excessive alcohol use. Also, a diet lacking in fruits and vegetables, gastroesophageal reflux disease, exposure to occupational toxic substances, and rising incidences of viral infections, including human papillomavirus and Epstein Barr virus are boosting its growth in the market. Oncology-specific pharmaceutical companies keep on launching enhanced therapeutics for the sake of the well-being of patients. For instance, according to the American Cancer Society’s most recent estimates for oral cavity and oropharyngeal cancers in the U.S. for 2023 are about 54,540 new cases of oral cavity or oropharyngeal cancer. Thus, amongst cancer types, the pharyngeal category is expected to witness higher CAGR during the forecast period.
“Amongst treatment type, chemotherapy held a significant share in the market in 2022”
Based on treatment type, the market is categorized into radiation therapy, surgery, chemotherapy, targeted drug therapy, and others. The chemotherapy segment is dominating the market in 2022 owing to the maximum effectiveness of chemotherapy in killing cancer cells using X-rays and protons to deliver radiation to the cancer cells. Additionally, there has been increased incidences of throat cancer globally which is a driving factor for this segment. For instance, according to mesothelioma.com’s report in June 2023, 25% of cancer patients receive chemo each year in the U.S., when compared to forgoing treatment, chemotherapy can double survival for some patients. Thus, among treatment types, chemotherapy held a significant share of the market in 2022.
Throat Cancer Therapeutics Market Report Coverage
“Amongst end users, the hospital segment to grow with high CAGR during the forecast period”
Based on end users, the market is segmented into hospitals, ambulatory surgical centers, and others. The hospital segment is anticipated to grow with a high CAGR during the forecast period owing to rising hospital admissions due to a surge in the prevalence of throat cancer leading to increased surgical procedures. Other factors, including increasing oncology expenditure, rising patient awareness levels for throat cancer, and availability of advanced hospital infrastructure, increased number of specialty hospitals in developed countries are factors expected to result in the dominance of the segment during the forecast period. For instance, in June 2023, a North India-based single-center hospital cancer registry study included all primarily diagnosed head and neck cancer cases attending the hospital till December 2020, in which a total of 574 confirmed cases of head and neck cancer were reported. Thus, amongst end-users, the hospital category is expected to witness a higher CAGR during the forecast period.
“Amongst regions, North America held a significant share of the market in 2022”
North America is dominating the market in the current scenario of 2022 due to the increasing smoke pollution, increasing alcohol consumption, and rising number of investments in developing effective throat cancer therapeutics. Government organizations are initiating throat cancer awareness programs to provide efficient care to patients. For example, In July 2023, the American Association for Cancer Research and the American Head and Neck Society organized the third AACR-AHNS Joint Conference on Head and Neck Cancer in Montreal. to present their latest research and provide critical updates on head and neck cancer biology, detection, imaging, prevention, and therapy, among other topics. The AACR also awards research grants to investigators pursuing promising research related to head and neck cancer. Thus, amongst regions, North America held a significant share of the market in 2022.
Q1: What is the current market size and growth potential of the throat cancer therapeutics market?
Ans: The throat cancer therapeutics market was valued at USD 6.5 Billion in 2022 and is expected to grow a CAGR of 8.5% during the forecast period (2023-2030).
Q2: What are the driving factors for the growth of the throat cancer therapeutics market?
Increased consumption of alcohol and tobacco, the surge in awareness programs regarding throat cancer, and rising investments in oncology departments are the driving factors for the growth of the throat cancer therapeutics market.
Q3: Which segment has the largest share of the throat cancer therapeutics market by cancer type?
Ans: The laryngeal cancer segment has the largest share of the throat cancer therapeutics market by cancer type.
Q4: What are the emerging technologies and trends in the throat cancer therapeutics market?
Ans: Transplantation and cellular therapy, molecular diagnostic assays and epigenetics products, and Digital Light Cycler System PCR, and AI- integrated diagnostic systems are the emerging technologies and trends in the throat cancer therapeutics market.
Q5: Which region will dominate the throat cancer therapeutics market?
Ans: North America is expected to dominate the market during the forecast period.
Q6: Who are the key players operating in the throat cancer therapeutics market?
Ans: Amgen Inc.; AstraZeneca; Bayer AG; Bristol Myers Squibb Company; Celldex Therapeutics; Lilly; Merck KGaA; Pfizer Inc.; Regeneron Pharmaceuticals Inc.; and Sanofi are the key players operating in the throat cancer therapeutics market.
Reasons to buy this report:
Customization Options:
The global Throat cancer therapeutics market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
1. Market Introduction
2. Research Methodology Or Assumption
3. Market Synopsis
4. Executive Summary
5. Impact Of Covid-19 On The Throat Cancer Therapeutics Market
6. Throat Cancer Therapeutics Market Revenue (usd Bn), 2020-2030f
7. Market Insights By Cancer Type
8. Market Insights By Treatment Type
9. Market Insights By End-user
10. Market Insights By Region
11. Throat Cancer Therapeutics Market Dynamics
12. Throat Cancer Therapeutics Market Opportunities
13. Throat Cancer Therapeutics Market Trends
14. Demand And Supply-side Analysis
15. Value Chain Analysis
16. Competitive Scenario
17. Company Profiled
18. Disclaimer
Research Methodology for the Throat Cancer Therapeutics Market Analysis (2023-2030)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global throat cancer therapeutics market were the three major steps undertaken to create and analyze the adoption of throat cancer therapeutics in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global throat cancer therapeutics market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the throat cancer therapeutics market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the throat cancer therapeutics market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as cancer type, treatment type, end-user, and regions. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the throat cancer therapeutics market. Further, we conducted factor analysis using dependent and independent variables such as cancer type, treatment type, end-user, and regions of throat cancer therapeutics. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the throat cancer therapeutics market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global throat cancer therapeutics market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2030 00for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global throat cancer therapeutics market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of cancer type, treatment type, end-user, and regions in the global throat cancer therapeutics market.
The main objective of the Global Throat Cancer Therapeutics Market Study
The current & future market trends of the global throat cancer therapeutics market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
